FOLFIRI Combined with Bevacizumab as First-Line Treatment for Metastatic Colorectal Cancer Patients with Hyperbilirubinemia after UGT1A1 Genotyping

OBJECTIVE: To report a metastatic colorectal cancer patient with hyperbilirubinemia treated with a combination of bevacizumab and FOLFIRI (5-fluorouracil, leucovorin, and irinotecan) using uridine diphosphate glucuronosyl transferase (UGT1A1) genotyping. CLINICAL PRESENTATION AND INTERVENTION: A 46-...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Yung-Sung, Huang, Meng-Lin, Chang, Se-Fen, Chen, Chin-Fan, Hu, Huang-Ming, Wang, Jaw-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586907/
https://www.ncbi.nlm.nih.gov/pubmed/24642571
http://dx.doi.org/10.1159/000358799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586907/
https://www.ncbi.nlm.nih.gov/pubmed/24642571
http://dx.doi.org/10.1159/000358799

Ejemplares similares